ArticleScientific reports2021

Ex vivo dendritic cell-based (DC) vaccine pulsed with a low dose of liposomal antigen and CpG-ODN improved PD-1 blockade immunotherapy.

Mona Yazdani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.